Acquisition of Guidant

Boston Scientific Corporation
2005 - 2006

Our attoneys represented Boston Scientific Corporation, the world's largest medical device company dedicated to less-invasive medicine, in its US$27-billion acquisition of Guidant Corporation with respect to the Federal Trade Commission's investigation of the transaction. The transaction included a US$4-billion pre-closing divestiture to Abbott Laboratories of Guidant's endovascular solutions and vascular intervention businesses but allowed Boston Scientific to retain rights with respect to Guidant's drug-eluting stent portfolio. The firm also obtained clearance in the EU and multiple other jurisdictions worldwide.

Email Disclaimer